GlassScriptPhysician profile
Caroline Grace Millan
NPI 1700834421
$1,219.06
in general payments reported to CMS, 2019-2025
15 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $34.33 · 2021: $31.54 · 2022: $237 · 2023: $343 · 2024: $135 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372 · Education: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.97 |
| Education | $350.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $537.45 | 2022-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $146.00 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $130.65 | 2021-2025 | |
| Therapeuticsmd, INC. | $90.59 | 2020-2022 | |
| Avion Pharmaceuticals | $74.37 | 2019-2022 | |
| Pfizer INC. | $50.35 | 2022-2023 | |
| Abbvie INC. | $48.55 | 2019 | |
| Amag Pharmaceuticals, INC. | $23.85 | 2019 | |
| Novo Nordisk INC | $22.80 | 2023 | Wegovy |
| Amgen INC. | $20.52 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.50 | 2022 | |
| Coopersurgical, INC. | $18.30 | 2025 | Paragard T 380a |
| Lupin INC. | $12.40 | 2019 | |
| Scynexis, INC. | $11.71 | 2022 | |
| Organon LLC | $11.02 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Millan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.